Back to Current Daily Care News Daily Care News from 2003

Daily Care News from 2003

  1. Acute Effects of Different Intensities of Exercise in Normoalbuminuric/ Normotensive Patients With Type 1 Diabetes. (28 December 2003)
  2. Exercise Capacity and Body Composition as Predictors of Mortality Among Men With Diabetes. (28 December 2003)
  3. Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. (28 December 2003)
  4. Benefits of blood pressure reduction in diabetic patients. (28 December 2003)
  5. A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension. (28 December 2003)
  6. Recommendations for the management of special populations: renal disease in diabetes. (28 December 2003)
  7. Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy. (28 December 2003)
  8. Clinical Decisions Regarding HbA1c Results in Primary Care. (28 December 2003)
  9. Autonomic neuropathy and gastrointestinal motility disorders in children and adolescents with type 1 diabetes mellitus. (21 December 2003)
  10. Parents Want to Know if Their Child Is at High Risk of Getting Diabetes. (21 December 2003)
  11. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. (21 December 2003)
  12. Influence of Trans Fatty Acids on Health. (21 December 2003)
  13. Life as a doctor with diabetes. (14 December 2003)
  14. The journey to metabolic control in diabetes: Many more miles to go. (14 December 2003)
  15. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine hagedorn insulin. (14 December 2003)
  16. Huge numbers must change lifestyle to prevent epidemic of diabetes examines the challenge of type 2 diabetes. (14 December 2003)
  17. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. (14 December 2003)
  18. Recent clinical trials of iodixanol. (14 December 2003)
  19. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. (7 December 2003)
  20. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine hagedorn insulin. (7 December 2003)
  21. TIME Magazine's cover story for December 8, 2003 is about Why So Many Of Us Are Getting Diabetes. See also Local girl on 'Time' cover. (7 December 2003)
  22. Conceptual Framework for a New Tool for Evaluating the Quality of Diabetes Consumer-Information Web Sites. (7 December 2003)
  23. Effect of therapy with insulin glargine (Lantus(R)) on glycemic control in toddlers, children, and adolescents with diabetes. (30 November 2003)
  24. The accuracy of the GlucoWatch G2 biographer in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. (30 November 2003)
  25. The accuracy of the CGMS in children with type 1 diabetes: results of the diabetes research in children network (DirecNet) accuracy study. (30 November 2003)
  26. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects. (30 November 2003)
  27. Body composition in adolescent girls with Type 1 diabetes. (30 November 2003)
  28. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. (30 November 2003)
  29. The influence exercised by the spouse or partner on diabetics. (30 November 2003)
  30. Grading and disease management in national screening for diabetic retinopathy in England and Wales. (30 November 2003)
  31. Insulin Treatment: New Technology, New Preparations. (23 November 2003)
  32. Blood Glucose Monitoring. (23 November 2003)
  33. Living With Diabetes. (23 November 2003)
  34. Hypoglycemia in children with type 1 diabetes: current issues and controversies. (23 November 2003)
  35. Metformin May Improve Metabolic Control in Adolescents with Type I Diabetes. (23 November 2003)
  36. Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients. Free full text is available in both HTML and PDF formats. (23 November 2003)
  37. Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes. (23 November 2003)
  38. Aspirin for diabetic retinopathy. (23 November 2003)
  39. Intensive education for lifestyle change in diabetes. (23 November 2003)
  40. Effectiveness of a rural pediatric diabetes management program. (23 November 2003)
  41. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes. (23 November 2003)
  42. Sweeteners and Beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients. (23 November 2003)
  43. Counseling Patients About Complications of Diabetes. (23 November 2003)
  44. Novo Nordisk Discontinues Velosulin® BR. (16 November 2003)
  45. Insulin Pump Therapy in Patients with Type 1 Diabetes Mellitus: Results of the Nationwide Quality Circle in Germany (ASD) 1999 - 2000. (16 November 2003)
  46. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. (16 November 2003)
  47. Eli Lilly and Company Has Recalled Sterile Diluent for Humulin L. See also FDA Enforcement Report and search for "humulin" to find citation. (16 November 2003)
  48. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus. (16 November 2003)
  49. Cost and Utilization Comparisons Among Propensity Score-Matched Insulin Lispro and Regular Insulin Users. (16 November 2003)
  50. Misadventures in Insulin Therapy: Are Your Members at Risk? (16 November 2003)
  51. The Medical Journal of Australia has two new articles: Recent advances in therapy of diabetes and Preventing complications of diabetes. (16 November 2003)
  52. Quality of life in school-aged children with type 1 diabetes on intensive treatment and their parents. (16 November 2003)
  53. Coping in Parents of children who are Chronically Ill: Strategies for Assessment and Intervention. (16 November 2003)
  54. Diabetes management improves when patients, doctors agree on treatment goals, UMHS study finds. (16 November 2003)
  55. A comparison of health-related quality of life of elderly and younger insulin-treated adults with diabetes. (16 November 2003)
  56. Mothers' perceptions of self-care in school-age children with diabetes. (9 November 2003)
  57. Parent and Child Reporting of Negative Life Events: Discrepancy and Agreement across Pediatric Samples. (9 November 2003)
  58. The American Association of Clinical Endocrinologists has released its Medical Guidelines for the Clinical use of Dietary Supplements and Nutraceuticals. (946 KB PDF file) See also New AACE Medical Guidelines for Use of Dietary Supplements; Endocrinologists Encourage Education Before Use. (2 November 2003)
  59. Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. (2 November 2003)
  60. Dutch study finds lower HbA1c and satisfaction with treatment in group that switched from MDI to pump therapy. (2 November 2003)
  61. No increased risk of developing depression in diabetes compared to other chronic illness. (2 November 2003)
  62. Gastrointestinal Symptoms in Type 1 Diabetic Patients, as Compared to a General Population. A Questionnaire-Based Study. (2 November 2003)
  63. Diabetes mellitus: a cardiovascular disease. (2 November 2003)
  64. Polycystic ovary syndrome in adolescence. (2 November 2003)
  65. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. (26 October 2003)
  66. Comparability of venous and capillary glucose measurements in blood. (26 October 2003)
  67. Timing of Changes in Interstitial and Venous Blood Glucose Measured With a Continuous Subcutaneous Glucose Sensor. (26 October 2003)
  68. Alternative routes of insulin delivery. (26 October 2003)
  69. Is overweight in patients with type 1 diabetes in the puberty a problem? (26 October 2003)
  70. Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes. (26 October 2003)
  71. Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes. (26 October 2003)
  72. Sustained Effect of Intensive Treatment of Type 1 Diabetes Mellitus on Development and Progression of Diabetic Nephropathy. (26 October 2003)
  73. General Quality of Life in Youth With Type 1 Diabetes. (26 October 2003)
  74. The Insulin Pump in Infants and Young Children. (26 October 2003)
  75. Counseling Diabetic Patients About Alcohol Use. (26 October 2003)
  76. Anaemia in patients with diabetes: unrecognised, undetected and untreated? See also Anaemia in Diabetics Often Unrecognised, Undetected, and Untreated. (26 October 2003)
  77. The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. (26 October 2003)
  78. American Dental Association/Colgate course addresses special oral health needs of diabetics. See also Considerations for Treating the Dental Patient With Diabetes. (26 October 2003)
  79. Third-Party Reimbursement for Diabetes Care, Self-Management Education, and Supplies. (19 October 2003)
  80. Recent advances in therapy of diabetes. (19 October 2003)
  81. The 1 September 2003 issue of the Medical Journal of Australia is devoted to chronic illness. Selected articles of interest include: (19 October 2003)
    1. Children with chronic conditions.
    2. Chronic illness in adolescents.
    3. Using information technology to improve the management of chronic disease.
    4. Getting it right: why bother with patient-centred care? (19 October 2003)
  82. Statin Treatment in Diabetes Mellitus. See also Statin Treatment in Diabetic Subjects: What the Heart Protection Study Shows. (19 October 2003)
  83. Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus. (19 October 2003)
  84. Thyroid function in children with newly diagnosed type 1 diabetes mellitus. (19 October 2003)
  85. Rotator cuff repair in patients with type I diabetes mellitus. (19 October 2003)
  86. Timing of fetal growth acceleration in women with insulin-dependent diabetes. (19 October 2003)
  87. Glucose Control and Mortality in Critically Ill Patients. (19 October 2003)
  88. 'Human' insulin versus animal insulin in people with diabetes mellitus. (12 October 2003)
  89. Retrospective review of care and outcomes in young adults with type 1 diabetes. Also in PDF format. (12 October 2003)
  90. Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old.. (12 October 2003)
  91. Concordance and children's use of medicines offers recommendations on teaching children about medicines. (12 October 2003)
  92. ACCP: Pioglitazone May Help Children With Type 2 Diabetes Mellitus. (12 October 2003)
  93. Pediatric diabetic ketoacidosis. (5 October 2003)
  94. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. (5 October 2003)
  95. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. (5 October 2003)
  96. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. (5 October 2003)
  97. Sugars and starch in the nutritional management of diabetes mellitus. (5 October 2003)
  98. Reducing Acute Adverse Outcomes in Youths With Type 1 Diabetes: A Randomized, Controlled Trial. (5 October 2003)
  99. Clinical characterisation of severe hypoglycaemia - a prospective population-based study. (5 October 2003)
  100. Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. (5 October 2003)
  101. Helping Kids With Diabetes Enjoy Halloween and the Holidays: With Planning, They Can Enjoy Treats — And That's No Trick. (5 October 2003)
  102. Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. (28 September 2003)
  103. Is HbA1c Affected by Glycemic Instability? (28 September 2003)
  104. Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. (28 September 2003)
  105. Hypoglycemia warning signal and glucose sensors: requirements and concepts. (28 September 2003)
  106. Continuous Glucose Monitoring: Reliable Measurements for up to 4 Days with the SCGM1 System. (28 September 2003)
  107. A wireless diabetes management and communication system. (28 September 2003)
  108. Design, methods, and evaluation directions of a multi-access service for the management of diabetes mellitus patients. (28 September 2003)
  109. Role for beta-blockers in the management of diabetic kidney disease. (28 September 2003)
  110. Screening for diabetic retinopathy: a cause for concern in people who drive. (28 September 2003)
  111. Intimacy and women with type 2 diabetes: an exploratory study using focus group interviews. (28 September 2003)
  112. Health care use by diabetic patients in the Netherlands: patterns and predicting factors. (21 September 2003)
  113. How Long Should Insulin Be Used Once a Vial Is Started? (14 September 2003)
  114. Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes. (14 September 2003)
  115. Diabetic Retinopathy: Contemporary prevalence in a well-controlled population. Also in PDF format. (14 September 2003)
  116. Use of the Internet to optimize self-management of type 1 diabetes: preliminary experience with DiasNet. See also DiasNet--a diabetes advisory system for communication and education via the Internet and DiasNet Home. (14 September 2003)
  117. Self-reported social class, self-management behaviors, and the effect of diabetes mellitus in urban, minority young people and their families. (14 September 2003)
  118. Medtronic Advises Paradigm 511 and 512 Users Not to Wear Pumps in Water. (2 September 2003)
  119. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. See also Diabetic Children Prefer Pump Over Injections. (7 September 2003)
  120. Family knowledge about the problematics of patients with diabetes mellitus. (7 September 2003)
  121. Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial-mechanisms and implications. (7 September 2003)
  122. Cross-cultural comparisons of anxiety and depression in adults with type 1 diabetes. (7 September 2003)
  123. Microalbuminuria in diabetes mellitus. Efficacy of a new screening method in comparison with timed overnight urine collection. (7 September 2003)
  124. Glucose Control is Not Improved by Accelerating Gastric Emptying in Patients with Type 1 Diabetes Mellitus and Gastroparesis. A Pilot Study with Cisapride as a Model Drug. (7 September 2003)
  125. Patient education: perspective of adolescents with a chronic disease. (7 September 2003)
  126. Poor glycaemic control caused by insulin induced lipohypertrophy. Also available in PDF format. (31 August 2003)
  127. Parent-adolescent Communication And Support For Diabetes Management As Reported By Adolescents With Type 1 Diabetes. (31 August 2003)
  128. Coping with everyday stress and links to medical and psychosocial adaptation in diabetic adolescents. (31 August 2003)
  129. Motivational/solution-focused intervention improves HbA1c in adolescents with Type 1 diabetes: a pilot study. (31 August 2003)
  130. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. (24 August 2003)
  131. Is digital image compression acceptable within diabetic retinopathy screening? (24 August 2003)
  132. Gastric Emptying of Solid and Liquid Meals in Healthy Controls Compared with Long-Term Type-1 Diabetes Mellitus under Optimal Glucose Control. (24 August 2003)
  133. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. (24 August 2003)
  134. 'Human' insulin versus animal insulin in people with diabetes mellitus. (17 August 2003)
  135. A novel use of u-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series. (17 August 2003)
  136. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus. (17 August 2003)
  137. Children with diabetes: perceptions of supports for self-management at school. (17 August 2003)
  138. Psychological aspects of diabetes mellitus. (17 August 2003)
  139. Patient education: perspective of adolescents with a chronic disease. (17 August 2003)
  140. Continuous subcutaneous insulin infusion in patients with diabetes mellitus. (17 August 2003)
  141. The effect of alcohol on blood glucose in Type 1 diabetes-metabolic modelling and integration in a decision support system. (17 August 2003)
  142. Diabetic retinopathy in children and adolescents. (17 August 2003)
  143. Insulin Glargine: An Updated Review of its Use in the Management of Diabetes Mellitus. (17 August 2003)
  144. The emerging role of electronic diaries in the management of diabetes mellitus. (17 August 2003)
  145. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. (17 August 2003)
  146. The August 2003 issue of Archives of Pediatrics & Adolescent Medicine is devoted to pediatric and childhood obesity, thought to be a major factor in the recent increase in type 2 diabetes in children. (17 August 2003)
  147. Retrospective review of care and outcomes in young adults with type 1 diabetes. Also available in PDF format. (10 August 2003)
  148. Severe hypoglycemia and long-term spatial memory in children with type 1 diabetes mellitus: A retrospective study. (10 August 2003)
  149. Children with diabetes: perceptions of supports for self-management at school. (10 August 2003)
  150. The demand for health education among patients with diabetes. (10 August 2003)
  151. Disetronic Issues Product Correction Notice. (3 August 2003)
  152. Diabetes and Driving Mishaps: Frequency and correlations from a multinational survey is the free, full text of a study that concludes that people with type 1 diabetes are at increased risk for driving mishaps. Also available in PDF format. (3 August 2003)
  153. Low–Glycemic Index Diets in the Management of Diabetes. Also available in PDF format. (3 August 2003)
  154. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes. (3 August 2003)
  155. Socio-psychological problems of patients with late adolescent onset type 1 diabetes--analysis by qualitative research. (3 August 2003)
  156. Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor. (3 August 2003)
  157. Novo Nordisk has discontinued Novolin® L [Lente] insulin. (27 July 2003)
  158. A Comparison of Postprandial and Preprandial Administration of Insulin Aspart in Children and Adolescents With Type 1 Diabetes. (27 July 2003)
  159. Diabetes and Driving Mishaps. (27 July 2003)
  160. Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes. (27 July 2003)
  161. Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus. (27 July 2003)
  162. Insulin lispro: a useful advance in insulin therapy. (27 July 2003)
  163. Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects. (27 July 2003)
  164. Higher frequency of paronychia (nail bed infections) in pediatric and adolescent patients with type 1 diabetes mellitus than in non-diabetic peers. (27 July 2003)
  165. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. (27 July 2003)
  166. Early detection of emotional and behavioural problems in children with diabetes: the validity of the Child Health Questionnaire as a screening instrument. (27 July 2003)
  167. A pilot study of motivational interviewing in adolescents with diabetes. (27 July 2003)
  168. Clinic Uses One Needle to Draw Blood From a Queue of Diabetes Patients illustrates the importance of ensuring that you always use a sterile, new needle or lancet whenever you are at clinic. (27 July 2003)
  169. The FDA has published the letter to Roche regarding the embargo of Disetronic insulin pumps, dated July 11, 2003. (20 July 2003)
  170. Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes. (20 July 2003)
  171. Insulin glargine: a systematic review of a long-acting insulin analogue. (20 July 2003)
  172. Postgraduate Medicine Online has several new online courses related to diabetes: (20 July 2003)
    1. Advances in insulin therapy (20 July 2003)
    2. Optimizing insulin regimens in type 1 diabetes (20 July 2003)
    3. Novel insulins and strict glycemic control (20 July 2003)
    4. The changing model of insulin use in type 2 diabetes (20 July 2003)
  173. Treatment of Hypertension in Adults With Diabetes. (20 July 2003)
  174. Expanded ABCs of Diabetes. (20 July 2003)
  175. A Cross-Sectional Study of Alcohol Consumption Patterns and Biologic Markers of Glycemic Control Among 459 Women. (20 July 2003)
  176. Intensive insulin treatment versus conventional regimen for adolescents with type 1 diabetes, benefits and risks. (13 July 2003)
  177. Usefulness of antioxidant vitamin supplementation in children and adolescents with newly diagnosed diabetes mellitus type I. (6 July 2003)
  178. Relationship between metabolic control and quality of life in adolescents with type 1 diabetes. Report from two Italian centres for the management of diabetes in childhood. (6 July 2003)
  179. Severe hypoglycemia and insulin antibodies in young type 1 diabetic patients. (6 July 2003)
  180. Severe hypoglycemia in diabetic children and adolescents: frequency and circumstances of occurrence. (6 July 2003)
  181. Thyroid autoantibodies in children with recently diagnosed insulin-dependent diabetes mellitus. (6 July 2003)
  182. Decreased consciousness of hypoglycaemia and the incidence of severe hypoglycaemia in children and adolescents with diabetes type 1. (6 July 2003)
  183. Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump). (6 July 2003)
  184. Bacterial and fungal flora in some clinical materials in children with diabetes type 1. (6 July 2003)
  185. Telemedicine in the management of young patients with type 1 diabetes mellitus: a follow-up study. (6 July 2003)
  186. The evolution of treatment guidelines for diabetic nephropathy. (6 July 2003)
  187. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. (6 July 2003)
  188. Preconception care for women with type 1 diabetes. (6 July 2003)
  189. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. (6 July 2003)
  190. Comparison of Insulin Aspart and Lispro. (29 June 2003)
  191. New insulins and quality of life. (29 June 2003)
  192. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes. (29 June 2003)
  193. Effectiveness of a toll-free telephone hotline for children and adolescents with type 1 diabetes. A 5-year study. (29 June 2003)
  194. Effect of Antecedent Hypoglycemia on Counterregulatory Responses to Subsequent Euglycemic Exercise in Type 1 Diabetes. (29 June 2003)
  195. Estrogen Blunts Neuroendocrine and Metabolic Responses to Hypoglycemia. (29 June 2003)
  196. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. (29 June 2003)
  197. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies - a pilot study. (29 June 2003)
  198. Factors associated to ketoacidosis at diagnosis of type 1 diabetes in children. (29 June 2003)
  199. Summer camps and quality of life in children and adolescents with type 1 diabetes. See also Camps for children with T1DM. (29 June 2003)
  200. The Platelet in Diabetes. (29 June 2003)
  201. Self-Management Competence as a Predictor of Outcomes of Intensive Therapy or Usual Care in Youth With Type 1 Diabetes. (29 June 2003)
  202. Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients. (29 June 2003)
  203. Tight Glucose Control in Diabetes Lowers Risk of Atherosclerosis. See also Intensive Glycaemic Control Yields Benefits Years Later. (22 June 2003)
  204. GlucoWatch Biographer May Potentially Prevent Numerous Incidences of Severe Diabetic Complications. (22 June 2003)
  205. Effects of fructose on hepatic glucose metabolism. (22 June 2003)
  206. Study shows insulin detemir results in less variability in blood glucose compared to NPH insulin and insulin glargine. (Insulin Detemir is not yet available.) (22 June 2003)
  207. Specialist nurses in diabetes mellitus (Cochrane Review). (22 June 2003)
  208. Pump Up Your Knowledge of Insulin Pumps. (22 June 2003)
  209. Perioperative management of type 1 diabetes mellitus. (22 June 2003)
  210. Disetronic Pump Starts Stopped in US. (15 June 2003)
  211. The June 14, 2003 issue of the British Medical Journal focuses on the patient. The full text of all articles is available free, and are well worth reading. Especially good is Doctors' diagnosis: Diabetes, which recounts a UK physician's diagnosis with diabetes during medical school and his experiences with the UK health system over the years. (15 June 2003)
  212. Selected ADA abtracts related to hypoglycemia include: (15 June 2003)
    1. Patients with Type 1 Diabetes Mellitus Fail To Awake in Response to Hypoglycemia.
    2. Counterregulation during Spontaneous Nocturnal Hypoglycaemia in Adolescents with Type 1 Diabetes Mellitus.
    3. Incidence of Hypoglycemic Blood Glucose Values Versus Severe Hyoglycemic Events in Well-Controlled Patients with Diabetes Mellitus Type 1.
    4. Lengthening of the QT Interval during Clinical Episodes of Nocturnal Hypoglycemia in Adults with Type 1 Diabetes.
    5. Neuropsychological and Neuroimaging Evidence of Hippocampal Damage in Type I Diabetes: A Pilot Investigation.
    6. Effect of Weekly Hypoglycemia on Subsequent Cognition.
    7. Predicting Occurrence of Severe Hypoglycemia (SH) over the Next 24 Hours Based on SMBG Data.
    8. Reduction of Risk for Severe Hypoglycemia (SH) through Psychobehavioral Intervention.
    9. The Influence of Risk Factors on Hypoglycemia in Type 1 Diabetes Assessed by Continuous Subcutaneous Glucose Monitoring.
    10. Severity of Hypoglycemia and Hypoglycemia Unawareness Are Associated with the Extent of Unsuspected Nocturnal Hypoglycemia.
    11. Defective Glutamine Removal during Hypoglycemia in Type 1 Diabetes Mellitus.
    12. Caffeine Restores Disordered Brain Activation Patterns Associated with a Memory Task in Acute Hypoglycemia but Fails To Support Function.
    13. The Relationship between Glycemic Control and Hypoglycemia Using Insulin Glargine Versus NPH Insulin: A Meta-Regression Analysis in Type 2 Diabetes.
  213. Selected ADA abstracts about eye care and retinopathy include: (15 June 2003)
    1. Retrospective Trial of Daily Wear Contact Lenses in Diabetic Patients.
    2. Hemoglobin A1c Influence upon Retinopathy Progression.
    3. Improvement or Stabilization of Advanced Diabetic Retinopathy after Pancreas Transplantation.
    4. Automated Detection of Diabetic Retinopathy in Digital Retinal Images.
    5. Determinants of Retinal Blood Flow in Patients with Type 1 Diabetes.
  214. Selected ADA abstracts about diabetes in kids include: (15 June 2003)
    1. A Two Center Randomized Controlled Trial of Insulin Pump Therapy in Young Children with Diabetes.
    2. Can Coping Skills Training for School-Aged Youth and Their Parents Improve Psychosocial Well-Being and Metabolic Control?
    3. Adolescents with Type 1 Diabetes Prefer Ketone Testing in Blood.
    4. Celiac Disease (CD) in Pediatric Patients with Type 1 Diabetes: Younger Age at Diabetes Onset and Reduced Height in 127 Biopsy-Positive CD-Patients Compared to 19,535 Diabetic Subjects without CD.
    5. Abnormal Day/Night Ratio May Not Be a Predictive Marker for Microalbuminuria in Adolescents with Type 1 Diabetes Mellitus.
    6. Carotid Artery (CA) Structure and Function in Young Adults with Type 1 Diabetes (T1DM).
  215. Depression in adolescents with diabetes. (8 June 2003)
  216. Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. (8 June 2003)
  217. Depressive symptoms and the risk of type 2 diabetes mellitus in a US sample. (8 June 2003)
  218. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. (8 June 2003)
  219. Carbohydrate intake and biomarkers of glycemic control among US adults: the third National Health and Nutrition Examination Survey (NHANES III). (8 June 2003)
  220. Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study. (8 June 2003)
  221. A Randomized Clinical Trial Comparing Breakfast, Dinner, or Bedtime Administration of Insulin Glargine in Patients With Type 1 Diabetes. (1 June 2003)
  222. Hypoglycemia in Diabetes. (1 June 2003)
  223. Maternal management behaviors for young children with type 1 diabetes. (1 June 2003)
  224. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. (1 June 2003)
  225. Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus. (1 June 2003)
  226. Stress management training as related to glycemic control and mood in adults with Type 1 diabetes mellitus. (1 June 2003)
  227. Transdermal glucose monitoring opens a new age of diabetes management. (1 June 2003)
  228. Intensified Blood Glucose Monitoring Improves Glycemic Control in Stable, Insulin-Treated Veterans With Type 2 Diabetes. (1 June 2003)
  229. Patient-centered outcomes of diabetes self-care. Associations with satisfaction and general health in a community clinic setting. (1 June 2003)
  230. Delivery of diabetes care in rural Ethiopia: an experience from Gondar. (1 June 2003)
  231. Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes. (1 June 2003)
  232. Low-Carbohydrate Diet Better Than Low-Fat for Weight Loss, Insulin Sensitivity, and Triglycerides. (1 June 2003)
  233. Novel targets and therapeutic strategies for type 2 diabetes. (1 June 2003)
  234. New international consensus guidelines for new-onset diabetes after transplant. (1 June 2003)
  235. Achieving glycemic control in young children with type 1 diabetes: approaches, pitfalls and new technologies. (25 May 2003)
  236. An assessment of care of paediatric and adolescent patients with diabetes in a large district general hospital. (25 May 2003)
  237. Do Multivitamin Supplements Attenuate the Risk for Diabetes-Associated Birth Defects? (25 May 2003)
  238. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. (25 May 2003)
  239. Newer Insulins Analogues Prevent Hypoglycemic Episodes Compared To Conventional Insulins. (25 May 2003)
  240. Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. (25 May 2003)
  241. Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. (25 May 2003)
  242. Generalist-subspecialist communication about children with chronic conditions: an analysis of physician focus groups. (25 May 2003)
  243. The New England Journal of Medicine published two reports about low-carbohydrate diets, also called the Atkins Diet:
    1. A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity. (25 May 2003)
    2. A Randomized Trial of a Low-Carbohydrate Diet for Obesity. (25 May 2003)
  244. Hope Warshaw, MMSc, RD, CDE, a nationally recognized expert in nutrition and diabetes, wrote a response to "What if It's All Been A Big Fat Lie?", an article about the Atkins diet that was published in The New York Times on July 7, 2002. (25 May 2003)
  245. Barriers to the treatment of adolescent type 2 diabetes - a survey of provider perceptions. (25 May 2003)
  246. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. (25 May 2003)
  247. Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study. (25 May 2003)
  248. Combination therapy with Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus. (25 May 2003)
  249. PAS: Toddlers with Diabetes May Benefit from Switch to Insulin Pump Therapy. See also A Randomized, Controlled Study of Insulin Pump Therapy in Diabetic Toddlers. (18 May 2003)
  250. Insulin Pump Therapy in Preschool Children with Type 1 Diabetes concludes that "insulin pump therapy is safe and effective in young children with type 1 diabetes." Reported at the 2003 Annual Meeting of the Pediatric Academic Society. (18 May 2003)
  251. Blood glucose monitoring in the management of type 1 diabetes in childhood. (18 May 2003)
  252. Adolescents' behavioral autonomy related to diabetes management and adolescent activities/rules. (18 May 2003)
  253. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. (18 May 2003)
  254. Case study: feasibility of multisystemic therapy as a treatment for urban adolescents with poorly controlled type 1 diabetes. (18 May 2003)
  255. Stages of Change for Healthy Eating in Diabetes. (11 May 2003)
  256. Lantus® (Insulin Glargine [rDNA Origin] Injection) Receives FDA Approval for Flexible Administration. (11 May 2003)
  257. Findings reveal that insulin detemir (Levemir) sets new standard with improved predictability and control in basal bolus insulin therapy. (Insulin detemir is not yet approved by the FDA for sale in the US.) (11 May 2003)
  258. Inadequacy of in-school support for diabetic children. (4 May 2003)
  259. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. (4 May 2003)
  260. Dietary management for children and adolescents with diabetes mellitus: personal experience and recommendations. (4 May 2003)
  261. Do multivitamin supplements attenuate the risk for diabetes-associated birth defects? (4 May 2003)
  262. Two Consecutive Pregnancies in a Type 1 Diabetic under Treatment with Insulin Lispro. (4 May 2003)
  263. A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020. (4 May 2003)
  264. An assessment of care of paediatric and adolescent patients with diabetes in a large district general hospital. (4 May 2003)
  265. Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. (4 May 2003)
  266. Colonic transit time in diabetic patients - comparison with healthy subjects and the effect of autonomic neuropathy. (4 May 2003)
  267. Lilly Confirms Continuing Shortage of Glucagon Kits. (27 April 2003)
  268. Analytical performance of glucometers used for routine glucose self-monitoring of diabetic patients. (27 April 2003)
  269. Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime. (27 April 2003)
  270. Modem Transmission of Glucose Values Reduces the Costs and Need for Clinic Visits. (27 April 2003)
  271. Dietary Fats Do Not Contribute to Hyperlipidemia in Children and Adolescents With Type 1 Diabetes. (27 April 2003)
  272. Flying With Diabetes. (27 April 2003)
  273. Have Insulin, Will Fly: Diabetes Management During Air Travel and Time Zone Adjustment Strategies. (27 April 2003)
  274. Diabetic Kidney Disease: Preventing Dialysis and Transplantation. (27 April 2003)
  275. ABC of diabetes: Cardiovascular disease, hypertension, and lipids. (27 April 2003)
  276. Using risk tables to assess cardiovascular risk in type 2 diabetes has drawbacks. (27 April 2003)
  277. Aerogen halts development of its insulin inhaler. (27 April 2003)
  278. Medscape offers the full text of Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes. (Free registration required) (20 April 2003)
  279. Effectiveness of screening in preventing blindness due to diabetic retinopathy. (20 April 2003)
  280. Responses to Contraindications to the use of metformin. See also Contraindications to the use of metformin. (20 April 2003)
  281. Intensive telehealth management of five at-risk adolescents with diabetes. (20 April 2003)
  282. A nationwide study of continuous subcutaneous insulin infusion (CSII) in Denmark. (13 April 2003)
  283. A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes. (13 April 2003)
  284. A repeated cross-sectional survey of severe hypoglycaemia in 178 Type 1 diabetes mellitus patients performed in 1984 and 1998. (13 April 2003)
  285. Efficacy and Safety of Low-Carbohydrate Diets. (13 April 2003)
  286. Management of cystic fibrosis-related diabetes in adolescence. (13 April 2003)
  287. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. (13 April 2003)
  288. Friends with Diabetes offers guidance on diabetes and Pesach-Passover. (13 April 2003)
  289. Use of the GlucoWatch Biographer in Children With Type 1 Diabetes. This study was funded partially by the Children with Diabetes Foundation. (6 April 2003)
  290. Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control. (6 April 2003)
  291. Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. (6 April 2003)
  292. Impact of a high-monounsaturated-fat diet on lipid profile in subjects with type 1 diabetes. (6 April 2003)
  293. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. (6 April 2003)
  294. Fish and Long-Chain {omega}-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women. (6 April 2003)
  295. Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy. (6 April 2003)
  296. Treatment of diabetic nephropathy in its early stages. (6 April 2003)
  297. Progression of Retinopathy During Pregnancy in Type 1 Diabetic Women Treated With Insulin Lispro. (30 March 2003)
  298. The Impact of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia on Relatives of Patients With Type 1 Diabetes. (30 March 2003)
  299. Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes. (30 March 2003)
  300. Insulin Pump Therapy. (30 March 2003)
  301. Blood glucose estimations in adolescents with type 1 diabetes: predictors of accuracy and error. (30 March 2003)
  302. Accuracy of an Electrochemical Sensor for Measuring Capillary Blood Ketones by Fingerstick Samples During Metabolic Deterioration After Continuous Subcutaneous Insulin Infusion Interruption in Type 1 Diabetic Patients reports on the accuracy of blood ketone testing using the Precision Xtra meter (called the MediSense Optium in Europe). (30 March 2003)
  303. The Continuous Glucose Monitoring System Is Useful for Detecting Unrecognized Hypoglycemias in Patients With Type 1 and Type 2 Diabetes but Is Not Better Than Frequent Capillary Glucose Measurements for Improving Metabolic Control. (30 March 2003)
  304. Evolution of Analytical Performance in Portable Glucose Meters in the Last Decade. (30 March 2003)
  305. Clinical Impact of Prandial State, Exercise, and Site Preparation on the Equivalence of Alternative-Site Blood Glucose Testing. (30 March 2003)
  306. Rapid A1c Availability Improves Clinical Decision-Making in an Urban Primary Care Clinic. (30 March 2003)
  307. Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes. (30 March 2003)
  308. A Comparison of Diabetes Education Administered Through Telemedicine Versus in Person. (30 March 2003)
  309. Neurocognitive functioning in children with type-1 diabetes with and without episodes of severe hypoglycaemia. (23 March 2003)
  310. Illness uncertainty, perceived control, and psychological distress among adolescents with type 1 diabetes. (23 March 2003)
  311. Efficacy of Humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes. (23 March 2003)
  312. Continuous glucose monitoring with type 1 diabetes mellitus. (23 March 2003)
  313. The Role of Diabetes Health Care Professionals in Diabetes Discrimination Issues at Work and School. Also in PDF version. (23 March 2003)
  314. Lantus receives European approval for pediatric use. (23 March 2003)
  315. Insulin Pump Therapy ... Is it Right for You? is a 24-page brochure by Novo Nordisk and includes a $25 rebate on NovoLog. (23 March 2003)
  316. NovoLog now available in disposable, prefilled pen. (23 March 2003)
  317. Novo Nordisk offers several online, professional courses related to diabetes, including blood glucose monitoring, the basics of pump therapy, and insulin delivery systems. Free registration is required and CE credits are offered. (23 March 2003)
  318. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. (23 March 2003)
  319. Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children. Also in PDF version. (23 March 2003)
  320. Rationale and options for combination therapy in the treatment of Type 2 diabetes. (23 March 2003)
  321. Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. See also Ways Of Reducing Glycaemic Load Vary In Effects. (23 March 2003)
  322. Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life. Also available in PDF format. (23 March 2003)
  323. Parents who test their children's blood sugar during the night should read about new research which indicates that Sustained Reduced Sleep Can Have Serious Consequences. See also The Cumulative Cost of Additional Wakefulness: Dose-Response Effects on Neurobehavioral Functions and Sleep Physiology From Chronic Sleep Restriction and Total Sleep Deprivation. (23 March 2003)
  324. Creating Healthy Futures: An Innovative Nurse-Managed Transition Clinic for Adolescents and Young Adults With Special Health Care Needs. (23 March 2003)
  325. On Friday, March 7, CWD Founder Jeff Hitchcock gave a presentation at the AACE Pediatric Practice Management Workshop. (16 March 2003)
  326. Deltec alerts Cozmo users to bolus calculation problem. (16 March 2003)
  327. Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes. Also available in PDF format. (16 March 2003)
  328. Hyperglycemia in Acute Illness. (16 March 2003)
  329. High-complex carbohydrate or lente carbohydrate foods? (16 March 2003)
  330. FDA Proposes Labeling and Manufacturing Standards For All Dietary Supplements. (16 March 2003)
  331. Constant vigilance: Mothers' work parenting young children with type 1 diabetes. (9 March 2003)
  332. Controlled-Release Oxycodone Helps Resolve Sleep Problem in Patients with Diabetic Neuropathy. (9 March 2003)
  333. Alterations of left ventricular function in women with insulin-dependent diabetes mellitus during pregnancy. (9 March 2003)
  334. Optimism and adaptation to chronic disease: The role of optimism in relation to self-care options of type 1 diabetes mellitus, rheumatoid arthritis and multiple sclerosis. (9 March 2003)
  335. The Henry J. Kaiser Family Foundation offers A Consumer Guide to Handling Disputes with Your Employer or Private Health Plan. (9 March 2003)
  336. Potential Cracks in Accu-Chek Strip Vials. (2 March 2003)
  337. Caution About Pumps and Magnetic Fields. (2 March 2003)
  338. Hypoglycemia Prevalence in Prepubertal Children With Type 1 Diabetes on Standard Insulin Regimen: Use of Continuous Glucose Monitoring System. This study shows concludes that the "Use of standard insulin regimens results in high prevalence and large intraindividual variation in hypoglycemia, particularly at night." (2 March 2003)
  339. Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens. (2 March 2003)
  340. Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin Analogs. (2 March 2003)
  341. Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart. (2 March 2003)
  342. UK's NICE issues Guidance on the use of continuous subcutaneous insulin infusion for diabetes (26 page PDF). See also Media Briefing: Guidance on the use of continuous subcutaneous insulin infusion for diabetes and UK National Institute for Clinical Excellence Recommends Insulin Pump Therapy for Some Type 1 Diabetes Patients. (2 March 2003)
  343. ISPAD offers a statement about Global standardization and hamonization of HbA1c. (2 March 2003)
  344. Diagnostic criteria for diabetes revisited: making use of combined criteria. (2 March 2003)
  345. Carbs vs. sugar: Diabetic meal plans have changed. (2 March 2003)
  346. Psychosocial factors and diabetes-related outcomes following diagnosis of Type 1 diabetes in adults: The Edinburgh Prospective Diabetes Study. (23 February 2003)
  347. Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study finds that women with diabetes on HRT are at higher risk of death from all causes and ischaemic heart disease. (23 February 2003)
  348. A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy. (23 February 2003)
  349. Disetronic recalls D-TRON pumps; to replace them with D-TRONplus. (16 February 2003)
  350. Medtronic MiniMed Alerts Health Care Providers About Changes In Paradigm Pump And About Customer Service Refinements. (16 February 2003)
  351. Standards of Medical Care for Patients With Diabetes Mellitus. (16 February 2003)
  352. Social factors associated with prolonged hospitalization among diabetic children. (16 February 2003)
  353. Roche to purchase Disetronic. See also Public Tender Offer by Roche to Disetronic Shareholders for Infusion Systems Business and Shaping the Future of Diabetes Care, a presentation used by Roche and Disetronic management at the investor conference call discussing the acquisition. (16 February 2003)
  354. The Business of Insulin: A Relationship Between Innovation and Economics. (16 February 2003)
  355. The Drug Bureaucracy by Henry I. Miller describes the nature of drug review at the FDA. (16 February 2003)
  356. Clarifying the Role of Insulin in Type 2 Diabetes Management. (16 February 2003)
  357. Stanford University is recruiting patients with type 2 diabetes for an online diabetes management study. (16 February 2003)
  358. Effects of metabolic control on vitamin E nutritional status in children with type 1 diabetes mellitus. (2 February 2003)
  359. Help Wanted: Pediatric Endocrinologists highlights the growing shortage of pediatric endocrinologists. (2 February 2003)
  360. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. (2 February 2003)
  361. Differential Effects of Rosiglitazone and Metformin on Adipose Tissue Distribution and Glucose Uptake in Type 2 Diabetic Subjects. See also Rosiglitazone And Metformin Have Different Effects In Diabetics. (2 February 2003)
  362. Serum ACE Predicts Severe Hypoglycemia in Children and Adolescents With Type 1 Diabetes . (26 January 2003)
  363. The incidence of hypoglycaemia in children with type 1 diabetes and treated asthma. (26 January 2003)
  364. Secular trends in growth in diabetes: are we winning? (26 January 2003)
  365. Contraindications to the use of metformin. (26 January 2003)
  366. Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis. (26 January 2003)
  367. Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy. (26 January 2003)
  368. Target-Seeking Behavior of Plasma Glucose With Exercise in Type 1 Diabetes. (26 January 2003)
  369. Short-Term, Delayed, and Working Memory Are Impaired During Hypoglycemia in Individuals With Type 1 Diabetes. (26 January 2003)
  370. Psychologic and physiologic effects of dieting in adolescents. See also full text at Medscape (free registration required). (26 January 2003)
  371. Perioperative management of diabetes. (26 January 2003)
  372. Diabetes: time for a new regime? reviews the financial success of diabetes medications and the changes that loss of patent protection may bring. (26 January 2003)
  373. School problems in diabetic kids not from diabetes. (12 January 2003)
  374. Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog). (12 January 2003)
  375. A protocol for improved glycaemic control following corticosteroid therapy in diabetic pregnancies. (12 January 2003)
  376. Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients. (12 January 2003)
  377. FDA Clears Critical Diabetes A1C Test for Home Use. (12 January 2003)
  378. UK NHS diabetes strategy unveiled. (12 January 2003)
  379. Bedtime Snacks Recommended for Diabetics with Low Nocturnal Glucose Levels. (5 January 2003)
  380. Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. (5 January 2003)
  381. Diabetes services in the UK: third national survey confirms continuing deficiencies. (5 January 2003)

[ Current Daily Care News | News from 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]

  Back to Current Daily Care News Return to the Top of This Page

Last Updated: Thursday January 01, 2015 15:28:56
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.